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Current Exercise Behaviors of Breast Cancer Patients Diagnosed with
Chemotherapy-Induced Peripheral Neuropathy
Abstract
Introduction: Chemotherapy-induced peripheral neuropathy (CIPN) is a common, dose-limiting effect of
cancer therapy. The neuropathic pain associated with CIPN often has negative implications on an individual’s
quality of life (QOL) and has long been recognized as one of the more difficult types of pain to treat.
Treatment of neuropathic pain due to CIPN often requires a multidisciplinary approach, with much attention
focused on the use of pharmacological therapies. However, in most instances, these agents have been shown to
have additional negative side effects for cancer patients. Thus, other interventions that address the symptoms
of CIPN should be considered. One such possible intervention is exercise rehabilitation, which has previously
been reported effective in attenuating numerous cancer treatment-related toxicities and enhancing the QOL
of patients. However, to our knowledge, there have been no published clinical trials examining the role of
exercise in preserving neurological function following chemotherapy. As such, the purpose of this
investigation was to examine the current exercise habits of breast cancer patients who are diagnosed with
CIPN and the impact on pain and QOL.
Methods: 300 women listed in the Breast Cancer Registry of Greater Cincinnati database were recruited by
mail and asked to complete three questionnaires (McGill QOL, Leeds Assessment of Neuropathic Symptoms
and Signs, and Current Exercise Behaviors). Data was analyzed at the 0.05 level of significance using a
student’s t-test and a Pearson’s product moment correlation.
Results: 134 completed surveys were returned and analyzed (44.6% response rate). Overall, QOL and
exercise behaviors were moderately correlated (r = 0.56). Patients reported exercising an average of 2.3 d/wk
and an overall QOL of 4.7. Of the patients completing the recommended amount of physical activity (EX, n =
21), QOL was 6.3, which was significantly higher than patients who did not meet these recommendations
(SED, n = 113, p<0.001). Likewise, only 15% of EX patients reported experiencing pain compared to 72% of
SED patients (p<0.001). Conclusions: Based on these data, it seems likely that an exercise intervention would
be successful in attenuating symptoms of CIPN and improving the overall QOL of breast cancer patients.
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Introduction
Chemotherapy- induced peripheral neuropathy (CIPN) is a com-
mon ailment among those taking chemotherapeutic drugs. This condi-
tion is characterized by damage to the nervous system that is a direct 
result of the medications associated with chemotherapy. Little is known 
about the mechanisms responsible for the development of CIPN [1]. 
The peripheral toxicity involved with CIPN is specific to each chemo-
therapy drug class, and in most cases, appears to be dose and duration 
dependent, however it can evolve even after a single drug application 
[2]. The chemotherapy agents Docetaxel, Paclitaxel, or Vinorelbine are 
used to treat breast cancer, and often result in damage to central ner-
vous system pain pathways, resulting in neuropathic pain [3-6]. The 
presence and severity of neuropathic pain is often shown to be associat-
ed with impairments in walking, general activities, sleep, work, mood, 
enjoyment of life, and relationships with others [7,8].
Much effort has been made to explore pharmacological therapies to 
reduce CIPN. Some of these therapies provide modest improvements 
in neurological function. However, in most instances, these agents have 
been shown to have additional negative side effects for cancer patients, 
such as cardiac conduction defects, abnormalities in antidiuretic hor-
mone secretion, loss of balance, swelling in extremities, tremor, and in-
creased chemotherapy resistance [9-11]. Thus, other interventions that 
address the symptoms of CIPN should be considered. One intervention 
that has the potential of preventing or alleviating CIPN is exercise reha-
bilitation. Exercise has been shown to have a local effect on peripheral 
nerves, inducing changes in both the vasculature and metabolic sys-
tems [12]. Short-term exercise stimulates endothelium-dependent va-
sodilatation and endoneurial blood flow [13]. Long-term exercise has 
a positive effect on oxygen delivery, as increased blood flow exposes 
blood vessels to shear stress, which augments vasodilation [13]. Several 
studies have illustrated the beneficial effects of exercise in attenuating 
numerous cancer treatment-related toxicities and enhancing the qual-
ity of the lives of patients [14-21]. In addition, numerous studies on the 
effect of exercise in populations with diabetic peripheral neuropathy 
have produced promising results [22-24]. However, published clinical 
trials examining the role of exercise in preserving neurological function 
following chemotherapy are limited. Since breast cancer survivors rep-
resent the largest population of cancer survivors in the United States, 
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the purpose of this investigation was to examine the current exercise 
behaviors of breast cancer patients who were diagnosed with CIPN and 
to determine the resulting impact on their pain and quality of life.
Methods
Subjects
This investigation used a non-probability sample of convenience. 
Women who met the eligibility criteria and were listed in the Breast 
Cancer Registry of Greater Cincinnati (BCRGC) database were recruit-
ed by mail in the fall of 2010. The eligibility criteria included women 
who (a) have recently received a clinical diagnosis of CIPN, and (b) 
were currently taking the chemotherapy agents Docetaxel, Paclitax-
el, or Vinorelbine, and (c) were able to read and write English. The 
BCRGC is a database established by the University of Cincinnati, De-
partment of Environmental Health for the purpose of supporting stud-
ies that focus on breast cancer issues. Women who were breast cancer 
survivors and were located in the Greater Cincinnati area may become 
members by signing a consent form and completing a registration form 
that includes questions specific to the detection, diagnosis, and treat-
ment of their disease. A total of 300 women listed in the BCRGC met 
the eligibility criteria of the study. All procedures were approved by 
the Wright State University Institutional Review Board prior to data 
collection.
Data collection
The 300 women who met the eligibility criteria and agreed to be 
contacted received a packet that included a cover letter, the McGill 
Quality of Life questionnaire [25], the Leeds Assessment of Neuropath-
ic Symptoms and Signs questionnaire (LANSS) [26], a questionnaire 
to measure current exercise behaviors (Reigle), and a self-addressed, 
stamped envelope. Women were asked to return the completed ques-
tionnaires within two weeks of receiving the packet. Women who did 
not respond within two weeks were sent a reminder postcard.
Data analysis
 Descriptive statistics have been computed as means and standard 
deviations. A Pearson’s product moment correlation was used to de-
termine the relationship between QOL and current exercise behaviors 
for the group as a whole. A student’s T-test was used to compare the 
overall QOL ratings, as well as the prevalence of pain ratings, among 
patients who received the recommended amount of exercise compared 
to those who did not. All data was analyzed at the 0.05 level of signifi-
cance.
Results
Of the 300 surveys sent out, 134 completed surveys were returned 
and analyzed, giving a 44.6% response rate. The characteristics of the 
patients are summarized in Table 1. The distribution of QOL was nor-
mal. On average, patients reported exercising 2.3 d/wk (approximately 
69 min/wk) and rated their overall quality of life (QOL) as 4.7 on a 
10-point scale. CIPN impacted routine activities, functions, and behav-
iors in the areas of domestic, work, and social/leisure life. A moderate 
correlation was measured between QOL and current exercise behaviors 
for the group as a whole (r = 0.56). Table 2 summarizes the results of 
the Exercise Behaviors Survey for all respondents. Table 3 presents the 
results of the LANSS survey for all respondents.
Responses were analyzed to determine the percentage of patients 
completing the recommended amount of physical activity (at least 150 
min moderate-intense ex/wk and muscle strengthening activity 2 d/wk 
[27]. Approximately 15.6% of the patients surveyed reported meeting 
these recommended levels of physical activity (EX, n = 21). This group 
of patients reported an overall QOL of 6.3. As demonstrated in (Figure 
1), this was significantly higher than those patients who did not meet 
these recommendations (SED, n = 113), who reported an average over-
all QOL of 3.4 (p<0.001). Similarly, only 15% of EX patients reported 
experiencing pain compared to 72% of SED patients (p<0.001) (Figure 
2). The pain was frequently described as “tingling” and “numbness” 
and localized to “hands and feet”. Several respondents (n = 46) indi-
cated that this pain was “better when I exercise”.
Age at time of 
survey (yrs)
Age at time of 
diagnosis (yrs)
Education Level Race Length of 
Cancer 
Treatment







4.5 ± 6.4 mo’s
Table 1: Subject Characteristics. Values are means ± SE.
Type of Exercise Frequency/wk
Increase flexibility of arms and shoulders 2.39 ± 0.10
Increase strength of arms and shoulders 2.16 + 0.10
Increase flexibility of legs 2.48 + 0.11
Increase strength of legs 2.45 + 0.10
Increase strength and flexibility of upper body 2.16 + 0.10
Increase strength and flexibility of lower body 2.35 + 0.10
Balance exercises 2.03 + 0.11
Resistance training 1.97 + 0.09
Table 2:  Results from Exercise Behaviors Survey. Values are means ± SE. 
Questions % of respondents 
answering Yes
Would you describe your pain as pricking, tingling, pins and 
needles?
51 ± 1.2%
Does the skin in the painful areas look different than normal? 17.9 ± 0.5%
Is the skin sensitive to touch? 33.3 ± 1.7%
Does your pain come on suddenly in bursts when you are 
still?
42.3 ± 1.1%
Do you feel that skin temperature in the painful area has 
changed?
20.5 ± 2.1%
Does stroking the affected area with cotton wool produce 
pain?
9.2 ± 0.3%











   * 
Figure 1:  Overall Quality of Life Ratings.  Values are means  ± SE.  *p<0.001 
vs. SED.
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Discussion
The major finding in this investigation was that breast cancer pa-
tients with CIPN who received the recommended levels of physical 
activity reported a significantly higher overall QOL and experienced 
significantly less pain than their sedentary counterparts. CIPN af-
fected breast cancer patients’ routine activities, functions, and behav-
iors. While it is unknown if the sedentary individuals abstained from 
exercise because of their pain, the respondents who stated that their 
pain was “better when I exercise” indicates that it seems likely that an 
exercise intervention would be successful in attenuating symptoms of 
CIPN and improving the overall QOL of breast cancer patients.
With neuropathy, muscle mass atrophies and leads to significant 
decreases in muscular strength [28]. This decline in strength appears to 
be slow and progressive. It also appears to affect distal muscle groups 
more so than proximal muscles. Researchers have indicated that this 
muscle weakness translates into impaired motor performance skills 
and a reduced exercise capacity [29]. However, several studies have re-
ported improvements in muscular strength following moderate resis-
tance exercise programs in patients with hereditary motor and sensory 
neuropathies [30,31], as well as diabetic neuropathies, and those asso-
ciated with fibromyalgia and chronic fatigue [32-37]. In light of these 
findings, many researchers recommend that exercise training serve 
as an important component in the comprehensive treatment plan for 
patients with peripheral neuropathy [33,34,38]. Moderate-to-intense 
strength training and aerobic exercise appears to be well tolerated by 
these patients [38], and is associated with improvements in motor 
function and nerve conduction velocity [32,35], as well as improved 
muscle reinnervation and increased axon regeneration [39]. In addi-
tion, one investigation reported that low intensity treadmill exercise 
promoted Schwann cell proliferation in the injured peripheral nerve 
[40]. In light of these findings, it is feasible to assume that an individual 
who has experienced a reduction in muscular strength and functional 
ability due to CIPN may experience similar improvements following 
an exercise program.
It is not uncommon for individuals with cancer to experience pain. 
This pain may be triggered by the disease itself, or by its associated 
treatments. The direct effect of the tumor accounts for about 70% of 
the pain related to cancer, while approximately 15% of cancer pain is 
related to its treatments [41]. The pain associated with CIPN has long 
been recognized as one of the more difficult types of pain to treat. 
However, as explained earlier, it is possible that exercise may have a 
beneficial effect on pain. As illustrated by the respondents in the cur-
rent study, those individuals who exercised experienced significantly 
less pain than their sedentary counterparts. Likewise, it was noted that 
pain became “better” upon exercise. This finding is supported by sev-
eral studies conducted on healthy populations, whereby pain thresh-
olds and tolerance levels have been reported to increase both during 
and following exercise. In addition, intensity ratings of pain appear to 
decrease following exercise [42,43].
While literature examining the role of exercise on symptoms of 
pain related to CIPN is lacking, we believe that the existing tangential 
research supports the use of exercise as a means to attenuate general 
cancer related pain. Exercise during cancer treatment has been shown 
to have a beneficial effect on pain for breast cancer patients [44-47]. In a 
similar study to ours, Liou et al. [45] surveyed the daily physical activity 
levels of individuals who were undergoing chemotherapy, but were not 
diagnosed with CIPN. These authors reported that those patients who 
received the recommended 150 min/wk of moderate activity reported 
significantly less symptoms of pain than their sedentary counterparts.
In light of the findings and the literature surrounding this topic, 
it seems feasible to assume that a supervised exercise program would 
provide a beneficial effect on quality of life and pain associated with 
CIPN in breast cancer patients. More follow up investigations are war-
ranted.
Limitations
The most apparent limitation in the present study is the low re-
sponse rate from the breast cancer patients (44.6%). However, in sur-
vey research, no single response rate is considered a standard [48]. Mail 
surveys typically have lower response rates than other types of surveys 
[49]. In the present study, non respondents were sent a reminder post-
card in an attempt to increase the response rate; however, additional 
measures could have also been employed, such as personal contact. In 
addition, due to the lack of existing literature examining the effects of 
exercise on symptoms of CIPN, the authors had to look to the effects of 
exercise on symptoms of peripheral neuropathy in other chronic dis-
eases (i.e., diabetes) to make its generalizations. Thus, it is possible that 
an exercise program may not produce similar results in a breast cancer 
patient. Likewise, since the location of cancer will vary the symptoms 
related to CIPN, it is possible that the exercise response would produce 
a different outcome in another form of cancer.
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